Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus
Status:
Terminated
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to provide preliminary data about the efficacy and the
safety of the combination of tacrolimus with everolimus in the prophylaxis of the
graft-versus-host-disease (GvHD) in patients after allogeneic stem cell transplantation.